Feng J, Tang D, Wang J, Zhou Q, et al. SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, for recurrent or metastatic cervical cancer: a clinical expansion cohort of phase 1 study. Clin Cancer Res 2022 Jun 2. pii: 699316. doi: 10.1158/1078-0432.CCR-22-0346.
PMID: 35653122